Search
for
Sort by
Research 30 of 225
- Human Hair Follicle Benzo[a]pyrene and Benzo[a]pyrene 7,8-diol Metabolism: Effect of Exposure to a Coal Tar-Containing Shampoo
- Calcipotriol (Dovonex) scalp solution in the treatment of scalp psoriasis: comparative efficacy with 1% coal tar/1% coconut oil/0.5% salicylic acid (Capasal) shampoo, and long-term experience
- Novel stain‐free lecithinized coal tar formulation for psoriasis
- Generalized Pustular Psoriasis
- Psoriasis of the Scalp
- Safety of dermatologic medications in pregnancy and lactation
- Recent advances in the treatment of psoriasis
- Topical Treatments for Scalp Psoriasis
- Rapid high-performance liquid chromatogaphic method for detection of interindividual differences in carcinogen metabolism
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Dermatological medications and local therapeutics
- An Update on Scalp Psoriasis
- Pityriasis amiantacea following bone marrow transplant.
- Don't take dandruff lightly! / Nurul Nadiah Saripshah
- Psoriasis del cuero cabelludo etiología, diagnóstico y tratamiento
- A 30-Year-Old Man with Recurrent Scaling and Itching of the Scalp
- Common Topical Medications
- Effectiveness of medicated shampoo against hair loss
- A method on establishment of acne complex animal model
- Experimental Study on Anticomedone Effect of Anti-acne Gel of Curcuma in Rabbit Ear Acne Model
- Pityriasis amiantacea associated with Staphylococcus aureus super-infection in bedouin patients
- ROLE OF AYURVEDIC MANAGEMENT IN CHEMICAL TOXICITY OF COSMETICS: A REVIEW
- Case 1: Intractable Rash in a 7-month-old Boy
- Case 1: Intractable Rash in a 7-month-old Boy
- HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology
- IN OTHER JOURNALS
- Production and potential application of wood tar in dermatology and cosmetic
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- General Dermatology